These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2178704)

  • 21. Recombinant rhizopuspepsinogen. Expression, purification, and activation properties of recombinant rhizopuspepsinogens.
    Chen Z; Koelsch G; Han HP; Wang XJ; Lin XL; Hartsuck JA; Tang J
    J Biol Chem; 1991 Jun; 266(18):11718-25. PubMed ID: 2050673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigenic and antiheparin properties of human platelet factor 4 (PF4).
    Nath N; Lowery CT; Niewiarowski S
    Blood; 1975 Apr; 45(4):537-50. PubMed ID: 803847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.
    Rauova L; Zhai L; Kowalska MA; Arepally GM; Cines DB; Poncz M
    Blood; 2006 Mar; 107(6):2346-53. PubMed ID: 16304054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, purification, and active site mutagenesis of recombinant porcine pepsinogen.
    Lin XL; Wong RN; Tang J
    J Biol Chem; 1989 Mar; 264(8):4482-9. PubMed ID: 2494172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotactic activity of platelet alpha granule proteins for fibroblasts.
    Senior RM; Griffin GL; Huang JS; Walz DA; Deuel TF
    J Cell Biol; 1983 Feb; 96(2):382-5. PubMed ID: 6187750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of recombinant rabbit IL-8 in Escherichia coli and establishment of the essential involvement of IL-8 in recruiting neutrophils into lipopolysaccharide-induced inflammatory site of rabbit skin.
    Harada A; Sekido N; Kuno K; Akiyama M; Kasahara T; Nakanishi I; Mukaida N; Matsushima K
    Int Immunol; 1993 Jun; 5(6):681-90. PubMed ID: 8347559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-yield production of recombinant platelet factor 4 by harnessing and honing the gram-negative bacterial secretory apparatus.
    Ataei S; Taheri MN; Tamaddon G; Behzad-Behbahani A; Taheri F; Rahimi A; Zare F; Amirian N
    PLoS One; 2020; 15(5):e0232661. PubMed ID: 32379796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of cDNA encoding human basic fibroblast growth factor in E. coli.
    Iwane M; Kurokawa T; Sasada R; Seno M; Nakagawa S; Igarashi K
    Biochem Biophys Res Commun; 1987 Jul; 146(2):470-7. PubMed ID: 3304281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of mouse uterine peptidylarginine deiminase in Escherichia coli: construction of expression plasmid and properties of the recombinant enzyme.
    Ohsugi I; Takahara H; Shiraiwa M; Sugawara K
    Arch Biochem Biophys; 1995 Feb; 317(1):62-8. PubMed ID: 7872804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of heparin anticoagulation by recombinant platelet factor 4 in humans.
    Dehmer GJ; Fisher M; Tate DA; Teo S; Bonnem EM
    Circulation; 1995 Apr; 91(8):2188-94. PubMed ID: 7697848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia.
    Ziporen L; Li ZQ; Park KS; Sabnekar P; Liu WY; Arepally G; Shoenfeld Y; Kieber-Emmons T; Cines DB; Poncz M
    Blood; 1998 Nov; 92(9):3250-9. PubMed ID: 9787161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMR solution structure of the 32-kDa platelet factor 4 ELR-motif N-terminal chimera: a symmetric tetramer.
    Mayo KH; Roongta V; Ilyina E; Milius R; Barker S; Quinlan C; La Rosa G; Daly TJ
    Biochemistry; 1995 Sep; 34(36):11399-409. PubMed ID: 7547867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case series of recombinant platelet factor 4 for heparin reversal after cardiopulmonary bypass.
    Demma L; Levy JH
    Anesth Analg; 2012 Dec; 115(6):1273-8. PubMed ID: 22859690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo studies on the binding of heparin and its fractions with platelet factor 4.
    Walz DA; Hung GL
    Semin Thromb Hemost; 1985 Jan; 11(1):40-7. PubMed ID: 2983432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet factor 4 and the platelet secreted proteoglycan: immunologic characterization by crossed immunoelectrophoresis.
    Levine SP; Knieriem LK; Rager MA
    Blood; 1990 Feb; 75(4):902-10. PubMed ID: 1689191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serglycin-binding proteins in activated macrophages and platelets.
    Kolset SO; Mann DM; Uhlin-Hansen L; Winberg JO; Ruoslahti E
    J Leukoc Biol; 1996 Apr; 59(4):545-54. PubMed ID: 8613703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet factor 4 efficiently reverses heparin anticoagulation in the rat without adverse effects of heparin-protamine complexes.
    Cook JJ; Niewiarowski S; Yan Z; Schaffer L; Lu W; Stewart GJ; Mosser DM; Myers JA; Maione TE
    Circulation; 1992 Mar; 85(3):1102-9. PubMed ID: 1537108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and characterization of recombinant human ciliary neurotrophic factor from Escherichia coli.
    McDonald JR; Ko C; Mismer D; Smith DJ; Collins F
    Biochim Biophys Acta; 1991 Aug; 1090(1):70-80. PubMed ID: 1883844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of wild-type and mutated forms of the catalytic (alpha) subunit of Caenorhabditis elegans casein kinase II in Escherichia coli.
    Hu E; Rubin CS
    J Biol Chem; 1990 Nov; 265(33):20609-15. PubMed ID: 2243106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved method for purification of human platelet factor 4 by affinity and ion-exchange chromatography.
    Medici I; Di Martino A; Cella G; Callegaro L; Prosdocimi M
    Thromb Res; 1989 May; 54(4):277-87. PubMed ID: 2763268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.